← Eichor
Study identifier: NCT07122167 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

Condition: Peripheral Arterial Disease  ·  Sponsor: MDCECRO LLC

PhaseNA
Planned participants153
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This is a prospective, multi-center, single-arm post-market study evaluating the safety and effectiveness of the ZENFLEX Pro™ Drug-eluting Stent in treating femoropopliteal artery stenosis or occlusion. A total of 153 subjects will be followed at 1, 6, and 12 months. The primary endpoint is primary patency at 12 months.

This description comes directly from the study's public registry record.

Talk to the study team

Qiqing BO, Clinical Operations Manager  ·  +86 18610591755  ·  qq.bo@zyloxmedical.com

Always discuss trial participation with your own doctor first.

Locations (1)

CardiovascularChrzanów, Chrzanow, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07122167